Related Experiment Video
Updated: Apr 6, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control
Lu Wang1, Zhiwei Jiang1, Hao Qiu2
1Department of Clinical Laboratory, Danyang People's Hospital, Medical School of Southeast University Danyang 212300, China ; Department of Microbiology and Immunology, Medical School of Southeast University Nanjing 210009, China.
Objectives:
To date, a number of epidemiological studies have explored the association between CTLA-4 +49 A/G polymorphism and cancer risk with elusive results. To address this gap, we carried out a comprehensive meta-analysis.
Design And Methods:
Two reviewers independently searched the PubMed, EMBASE, CBM (Chinese BioMedical Disc) and China National Knowledge Infrastructure (CNKI) Databases for relevant studies up to December 20, 2014. Odds ratios (ORs) with 95% confidence intervals (CIs) for CTLA-4 +49 A/G polymorphism and cancer risk were used to evaluate the strength of association.
Results:
A total of 52 case-control studies were ultimately recruited. Our results showed the statistical evidence of an association between the CTLA-4 +49 A/G polymorphism and decreased risk of overall cancer in all the comparison models. In stratified analyses by cancer type, ethnicity and the origin of cancer, significant decreases in cancer risk were observed in breast cancer, lung cancer, other cancers epithelial tumor and Asians. In addition, in a stratified analysis by the system of cancer, significant decreases in cancer risk were found for reproductive and breast cancer, respiratory system cancer, and malignant bone tumor in all the genetic models, and other system cancer in two genetic models: GG+AG vs. AA and GG vs. AA.
Conclusions:
This meta-analysis suggests that the CTLA-4 +49 A/G polymorphism may be a protective factor for cancer.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancers Originate from Somatic Mutations in a Single Cell

